Cardoso Guinea B C, Maniglio Devid, Volpato Fabio Z, Tondon Abhishek, Migliaresi Claudio, Kaunas Roland R, Zavaglia Cecilia A C
University of Campinas, Materials Engineering Department, Faculty of Mechanical Engineering, Campinas, Brazil.
University of Trento, Department of Industrial Engineering, BIOtech Research Center, Trento, 38123, Italy.
J Biomed Mater Res B Appl Biomater. 2016 Aug;104(6):1076-82. doi: 10.1002/jbm.b.33457. Epub 2015 May 29.
Bone substitutes are required to repair osseous defects caused by a number of factors, such as traumas, degenerative diseases, and cancer. Autologous bone grafting is typically used to bridge bone defects, but suffers from chronic pain at the donor-site and limited availability of graft material. Tissue engineering approaches are being investigated as viable alternatives, which ideal scaffold should be biocompatible, biodegradable, and promote cellular interactions and tissue development, need to present proper mechanical and physical properties. In this study, poly(ε-caprolactone) (PCL), oleic acid (OA) and hydroxyapatite (HAp) were used to obtain films whose properties were investigated by contact angle, scanning electron microscopy, atomic force microscopy, tensile mechanical tests, and in vitro tests with U2OS human osteosarcoma cells by direct contact. Our results indicate that by using OA as surfactant/dispersant, it was possible to obtain a homogenous film with HAp. The PCL/OA/Hap sample had twice the roughness of the control (PCL) and a lower contact angle, indicating increased hydrophilicity of the film. Furthermore, mechanical testing showed that the addition of HAp decreased the load at yield point and tensile strength and increased tensile modulus, indicating a more brittle composition vs. PCL matrix. Preliminary cell culture experiments carried out with the films demonstrated that U2OS cells adhered and proliferated on all surfaces. The data demonstrate the improved dispersion of HAp using OA and the important consequences of this addition on the composite, unveiling the potentially of this composition for bone growth support. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1076-1082, 2016.
骨替代物被用于修复由多种因素引起的骨缺损,如创伤、退行性疾病和癌症。自体骨移植通常用于填补骨缺损,但存在供体部位慢性疼痛和移植材料可用性有限的问题。组织工程方法正在作为可行的替代方案进行研究,理想的支架应具有生物相容性、可生物降解性,并促进细胞相互作用和组织发育,还需要具备适当的机械和物理性能。在本研究中,聚(ε-己内酯)(PCL)、油酸(OA)和羟基磷灰石(HAp)被用于制备薄膜,通过接触角、扫描电子显微镜、原子力显微镜、拉伸力学测试以及与U2OS人骨肉瘤细胞的直接接触体外测试来研究其性能。我们的结果表明,通过使用OA作为表面活性剂/分散剂,可以获得含有HAp的均匀薄膜。PCL/OA/HAp样品的粗糙度是对照(PCL)的两倍,接触角更低,表明薄膜的亲水性增加。此外,力学测试表明,添加HAp降低了屈服点载荷和拉伸强度,并增加了拉伸模量,表明与PCL基质相比,该组合物更脆。用这些薄膜进行的初步细胞培养实验表明,U2OS细胞在所有表面上都能粘附和增殖。数据证明了使用OA时HAp的分散性得到改善,以及这种添加对复合材料的重要影响,揭示了这种组合物在支持骨生长方面的潜力。© 2015威利期刊公司。《生物医学材料研究杂志》B部分:应用生物材料,104B: 1076 - 1082,2016年。